This sustained MCP-1 expression may promote ongoing neuroinflammation, vasculitis, and atherosclerosis, thus elevating the postoperative risk of cerebrovascular accidents, acute coronary syndrome, and other organ dysfunction (10, 11, 26–30). This evidence concerns the gene CCL2 and acute coronary syndrome.